JHOP Articles

Skip to main content

FDA Updates, Lung Cancer

FDA Approves Tepmetko for Metastatic NSCLC and MET Exon 14 Skipping Alterations

From the Literature, Colorectal Cancer, Screening

Pembrolizumab Shows Long-Term Benefits in Patients with Metastatic Colorectal Cancer and MSI-H or dMMR

From the Literature, Transplant, Adverse Events

Sitagliptin, a DPP-4 Inhibitor, Reduces the Incidence of Acute GVHD After Stem-Cell Transplant

FDA Updates, Multiple Myeloma

Xpovio Approved for Patients with Relapsed or Refractory Multiple Myeloma

FDA Updates, Lung Cancer

Tagrisso Receives New Indication as Adjuvant Therapy for NSCLC with EGFR Mutations

FDA Updates, Lymphoma

Xalkori Approved for Anaplastic Large-Cell Lymphoma and ALK Mutation in Young Patients

FDA Updates, Breast Cancer

FDA Approves Margenza for the Treatment of Metastatic HER2-Positive Breast Cancer

FDA Updates, Prostate Cancer

Orgovyx First FDA-Approved Oral Hormone Therapy for Advanced Prostate Cancer

Meeting Highlights

ASH Highlights, Leukemia

Oral Vodobatinib Elicits Durable Responses in Heavily Pretreated Patients with Chronic Myeloid Leukemia

Meeting Highlights

ASH Highlights, Myelofibrosis

Momelotinib, a Novel JAK Inhibitor, Makes Inroads in Intermediate- or High-Risk Myelofibrosis

Page 96 of 199
Results 951 - 960 of 1986